|Day Low/High||2.04 / 2.13|
|52 Wk Low/High||0.49 / 5.19|
GW Pharmaceuticals saw its stock price surge amid news of a successful Epidiolex clinical trial. But that high also generated buzz across pot stocks at large.
Pot-related stocks have gone up in flames over the past year amid legal woes and failure to show any profits.
The SEC is warning investors about recent trading halts in five different marijuana stocks.
Penny stock publisher Peter Leeds finds most pot companies to be very high risk and cautions investors to wait until prices drop.
Small business owners in the marijuana field are finding that there is little security when your product is federally illegal.